Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Military Medical Academy

Source: Site record.

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

The Military Medical Academy (VMA), Belgrade is one of the largest and most advanced tertiary-care academic medical institutions in Southeast Europe, with strong capabilities and infrastructure supporting clinical research across multiple therapeutic areas. As part of the Serbian Ministry of Defence and affiliated with the University of Defence’s medical faculty, it integrates clinical care, education, and scientific research, positioning it as a center of excellence in both military and civilian healthcare. From a clinical research perspective, VMA offers a highly developed ecosystem, including 26 clinics, 11 research institutes, specialized centers, and over 1,200 beds, enabling large-scale and complex clinical studies. Its dedicated Center for Clinical Pharmacology plays a key role in coordinating clinical trials, including bioequivalence studies, pharmacovigilance, and therapeutic drug monitoring, indicating structured involvement in regulated clinical research activities.…

Source: Trial-derived.
106Total Trials
Source: Trial-derived.
12Recruiting Trials
Source: Trial-derived.
35Active Trials
Source: Trial-derived.
55Completed Trials
Source: Trial-derived.
80Unique Conditions
Source: Trial-derived.
71Unique Sponsors

Conditions

Source: Trial-derived. Crohn's Disease (10)Source: Trial-derived. Ulcerative Colitis (8)Source: Trial-derived. Lupus Erythematosus, Systemic (5)Source: Trial-derived. Systemic Lupus Erythematosus (5)Source: Trial-derived. Crohn Disease (4)Source: Trial-derived. Diabetes Mellitus, Type 2 (3)Source: Trial-derived. Rheumatoid Arthritis (3)Source: Trial-derived. Ulcerative Colitis (UC) (3)

Sponsors

Source: Trial-derived. AbbVie (15)Source: Trial-derived. Hoffmann-La Roche (8)Source: Trial-derived. Amgen (7)Source: Trial-derived. Pfizer (6)Source: Trial-derived. Boehringer Ingelheim (5)Source: Trial-derived. Military Medical Academy, Belgrade, Serbia (4)Source: Trial-derived. Takeda (4)Source: Trial-derived. ACADIA Pharmaceuticals Inc. (3)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Telehealth study visits
Source: AI-inferred. Electronic data capture
Source: AI-inferred. Electronic source (eSource) system

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. X-Ray

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. Pharmacokinetic bioanalysis
Source: AI-inferred. Specimen packaging and shipment

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Endoscopy / colonoscopy
Source: AI-inferred. Intravenous infusion administration

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. App-based insulin dose guidance
Source: AI-inferred. Blood glucose meter monitoring
Source: AI-inferred. Electronic participant diary platform
Source: AI-inferred. Electronic patient-reported outcome (ePRO) diary system
Source: AI-inferred. Measurable residual disease (MRD) assessment